New pages
From Xenbase
- 12:27, 18 February 2019 XB-FEAT-6469704 (hist) [327 bytes] JoshuaFortriede (talk | contribs) (Created page with "=acta4= This is the community wiki page for the gene ''acta4'' please feel free to add any information that is relevant to this gene that is not already captured elsewhere in...")
- 20:32, 24 January 2019 XB-MORPHOLINO-22060856 (hist) [68 bytes] Xenbase (talk | contribs) (Created page with "This morpholino previously had a duplicate - XB-MORPHOLINO-22061657.")
- 20:23, 24 January 2019 XB-MORPHOLINO-17251641 (hist) [66 bytes] Xenbase (talk | contribs) (Created page with "This morpholino previously had a duplicate XB-MORPHOLINO-17251693.")
- 18:35, 18 January 2019 XB-MORPHOLINO-17250199 (hist) [80 bytes] Xenbase (talk | contribs) (Created page with "This morpholino previously had a duplicate 'rara MO10' (XB-MORPHOLINO-22041777).")
- 18:26, 18 January 2019 XB-MORPHOLINO-19778018 (hist) [103 bytes] Xenbase (talk | contribs) (Created page with "There was previously a duplicate version of this morpholino named 'ascl1 MO3' (XB-MORPHOLINO-19756566).")
- 17:00, 14 January 2019 Ketamine (hist) [861 bytes] Xenbase (talk | contribs) (Created page with "==Description== "Ketamine is a cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors...")
- 17:26, 28 December 2018 XB-FEAT-6467132 (hist) [349 bytes] JoshuaFortriede (talk | contribs) (→ces3.5)
- 17:25, 28 December 2018 XB-FEAT-6467139 (hist) [348 bytes] JoshuaFortriede (talk | contribs) (→ces3.1)
- 17:17, 28 December 2018 XB-FEAT-6467124 (hist) [360 bytes] JoshuaFortriede (talk | contribs) (Created page with "On December 28, 2018 this gene was changed from ces1 to ces3.7. Evidence includes belonging to the ces3 gene tree in Ensembl as well as partial synteny to human ces3 gene.")
- 16:03, 19 December 2018 Alisertib (hist) [765 bytes] Xenbase (talk | contribs) (Created page with "==Description== "Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer." Source: [ http://www.drugbank.ca/drugs/DB052...")
- 14:02, 10 December 2018 Canertinib (hist) [737 bytes] Xenbase (talk | contribs) (Created page with "==Description== "Canertinib (CI-1033) is a pan-ErbB inhibitor for EGFR and ErbB2" Source: [https://www.selleckchem.com/products/CI-1033(Canertinib).html] File:Screen Shot...")
- 13:55, 10 December 2018 Mubritinib (hist) [711 bytes] Xenbase (talk | contribs) (Created page with "==Description== "Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2" Source: [https://www.selleckchem.com/products/Mubritinib-TAK-165.html] File:Screen Shot 2018-09-...")
- 13:43, 7 December 2018 2-Deoxyglucose (hist) [843 bytes] Xenbase (talk | contribs) (Created page with "==Description== "2-Deoxy-D-Glucose (2-Deoxyglucose) is a glucose analog that inhibits glycolysis via its actions on hexokinase, the rate limiting step of glycolysis." Source:...")
- 16:57, 28 November 2018 MK-2206 (hist) [647 bytes] Xenbase (talk | contribs) (Created page with "==Description== "An orally potent and highly selective non-ATP-competitive allosteric Akt inhibitor that has nanomolar IC50 values and broad preclinical anti-tumor activities....")
- 14:07, 20 November 2018 GANT 61 (hist) [803 bytes] Xenbase (talk | contribs) (Created page with "==Description== "GANT 61 is an inhibitor of Gli1 and Gli2 targeting the Hedgehog/GLI pathway". Source: [https://www.medchemexpress.com/GANT-61.html] File:Screen Shot 2018...")
